AHA 2019: Results From The Treat Stroke To Target (TST) Trial — Prof Pierre Amarenco

Просмотров: 165   |   Загружено: 5 год.
icon
Radcliffe Cardiology
icon
4
icon
Скачать
iconПодробнее о видео
Prof Pierre Amarenco (Paris University, Paris, FR) discuss the Benefit of a Target LDL Cholesterol Less Than 70 mg/dl After an Ischemic Stroke of Atherosclerotic Origin

Questions :
1. Why was the TST trial conducted?
2. What was design, patient population and endpoints?
3. What were your findings?
4. How should this study influence clinical practice and guidelines?
5. Will TST influence further research in this field?

Filmed on site at AHA 2019 by Radcliffe Cardiology.

See more videos here :

RC Academy :
radcliffecardiology.com is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. Radcliffe Cardiology also has a dedicated eLearning platform, RC Academy, which uses innovative platforms to host digital webinars, live case broadcasts and video roundtable discussions.

Похожие видео

Добавлено: 55 год.
Добавил:
  © 2019-2021
  AHA 2019: Results From The Treat Stroke To Target (TST) Trial — Prof Pierre Amarenco - RusLar.Me